Platelet-derived Microparticles increase the Expression of hTERT Gene in Umbilical Cord Mesenchymal Stem Cells

Authors

Abstract:

Background: Mesenchymal stem cells have been widely considered in clinical researches because of their self-renewality and differentiation into various tissues. Nevertheless, their limited in vitro life span, which occurs only after several divisions, makes some changes in these cells, which affects all of their characteristics and remarkably reduces their application. In this study, the effect of platelet-derived microparticles, a rich source of growth factors, proteins, enzymes and microRNAs, was evaluated on the expression of hTERT gene as one of the main factors, involved in aging process and cell longevity. Materials and methods: Umbilical cord-mesenchymal stem cells were used for this study. The cells were confirmed by evaluating their morphology and surface markers using inverted microscope and flow cytometry, respectively. Platelet microparticles were prepared by centrifuging platelet bags with different speeds, and their concentration was determined by Bradford assay. When confluency of cultured MSCs was 30%, cells were treated with 50 µg/mL of microparticles for 5 days, Then, RNA was extracted and cDNA was synthesized. The quantitative expression of hTERT gene was assessed using Real-Time PCR. Results: The fibroblast-like cells were isolated from umbilical cord tissue, and their mesenchymal markers were approved by flowcytometry. The results of Real-Time PCR showed that the expression of hTERT gene was increased more than 3 times compared with control group. Conclusion: It can be concluded that platelet-derived microparticles can potentially be recognized as a suitable, safe and effective method in increasing the hTERT gene expression and maybe life span of mesenchymal stem cells; however, further investigations is needed.  

Upgrade to premium to download articles

Sign up to access the full text

Already have an account?login

similar resources

Differentiation of Umbilical Cord Lining Membrane-Derived Mesenchymal Stem Cells into Endothelial-Like Cells

Background: Stem cell therapy for the treatment of vascular-related diseases through functional revascularization is one of the most important research areas in tissue engineering. The aim of this study was to investigate the in vitro differentiation of umbilical CL-MSC into endothelial lineage cells. Methods: In this study, isolated cells were characterized for expression of MSC-specific marke...

full text

Over expression of Nrf2 in Umbilical Cord-derived Mesenchymal Stem Cells Up regulates Cytoprotective Genes, TXNRD1 and GCLC

Background: Mesenchymal stem cells (MSCs) are ideal cells for cell and gene therapy. However, the low survival of MSCs after transplantation has limited their applications. We aimed to evaluate the expression of cytoprotective genes including NQO1, TXNRD1, HO-1, GCLC following the over expression of Nrf2 in umbilical cord-derived MSCs (UC-MSCs). Methods: 3-5 passages of UC-MSCs were cultured. ...

full text

The effects of umbilical cord Wharton jelly derived mesenchymal stem cells injection on diabetic wound healing in male rats

Background: The number of patients suffering from diabetic ulcers has been increased in recent years and the current therapies have faced failure. This study aimed to investigate the effects of Wharton’s jelly stem cells (WJMSCs) on the diabetic wound in an animal mode. Methods: During this laboratory experimental study carried out in Skin and Stem Cells Research Center from March 2021 to Nove...

full text

Gene Expression Profile of Adherent Cells Derived From Human Peripheral Blood: Evidence of Mesenchymal Stem Cells

Mesenchymal stem cells (MSCs) provide a novel option in cellular therapy and tissue engineering. Recent studies indicated that it is possible to obtain MSCs from peripheral blood by attachment ability to plastic surface. To evaluate adherent cells derived from peripheral blood, their expression profile and surface markers were investigated. The results of RT-PCR indicated that these cells expre...

full text

P 82: The Transplantation of Human Umbilical Cord Mesenchymal Stem Cells in Neonatal Strokes

Brain injuries that caused by strokes (result of intra partum ischemia) are a frequent cause of prenatal mortality and morbidity with limited therapeutic options. Transplanting human mesenchymal stem cells (hmscs) indicates improvement in hypoxic Ischemic brain injury (HIBD) by secretion growth factor stimulating repair processes (Hmscs) known as multi potent cells which isolated from bone marr...

full text

In-vitro Differentiation of Human Umbilical Cord Wharton’s Jelly Mesenchymal Stem Cells to Insulin-Producing Cells

  Background & Objective: Diabetes is a major chronic metabolic disease in the world. Islet transplantation is a way to treat diabetes. Unfortunately, this method is restricted due to graft rejection and lack of donor islets. Mesenchymal Stem Cells (MSCS) have the ability to differentiate into Insulin-Producing Cells (IPCs). In this study, Human Umbilical Mesenchymal Stem Cells (HUMSCS) were in...

full text

My Resources

Save resource for easier access later

Save to my library Already added to my library

{@ msg_add @}


Journal title

volume 5  issue 4

pages  0- 0

publication date 2017-11

By following a journal you will be notified via email when a new issue of this journal is published.

Keywords

Hosted on Doprax cloud platform doprax.com

copyright © 2015-2023